Cancer is a major public health problem worldwide and is expected to surpass infectious disease as the leading cause of mortality in Africa within the next two decades.
It is a group of genomic diseases that presents with intra- and inter-population unique phenotypes. At large, the prevention and personalized treatment of cancers have been driven by the understanding of the genetic make-up of the disease of mostly non-African populations. For this, it is needed to address the knowledge gap in understanding the underlying genetic causes of, and genomic alterations associated with, cancer among black Africans.
Lastly, it is related to disparities that include socioeconomic, ethnic, racial, and cultural factors that differ between low and high-income countries.
Retinoblastoma is the most common cancer in the paediatric population and Wilms tumor (WT) is the most common renal malignancy of childhood. Both with global disparities reported indicating highest incidence and lowest survival in sub-Saharan Africa.
Recently studies are focused on identifying the constitutional mutations within the African populations.
EU-STANDS4PM is a Coordinating and Support Action funded under the Horizon2020 framework programme of the European Commission. Its central goal is to develop harmonised transnational standards, recommendations and guidelines that allow a broad application of predictive in silico methodologies in personalised medicine across Europe.
This is the fourth call of ICPerMed “Best Practice in Personalised Medicine” Recognition. The objective of the ICPerMed Recognition 2021 is to honour, encourage, promote and disseminate outstanding evidence-based applications in the field of personalised medicine (PM), focusing on the implementation of PM research. It is open for candidates worldwide. We encourage to present your candidatures if you are interested.
The deadline for proposal submission is extended until 18th February 2022.
You can consult all the information related with this call here.
ERA PerMed Results of the Joint Transnational Call 2021
We are glad to announce the publication of ERA PerMed 7th Newsletter where you can find detailed description about the selected projects to be funded under ERA PerMed Joint Transnational Call for Proposals 2021 on “Multidisciplinary Research Projects on Personalised Medicine- Development of clinical support tools for personalised medicine implementation”.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok